SCHEMBL6760766

SCHEMBL6760766

CC(Nc1ccc2sc(C(=O)NCc3cccnc3)cc2c1)c1nc2ccccc2[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC40A1 Q9NP59 1/20 0.43
CLK1 P49759 1/20 0.43
POLB P06746 1/20 0.43
ADORA3 P0DMS8 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA2B P29275 1/20 0.42
LMNA P02545 5/20 0.41
ALDH1A1 P00352 4/20 0.41
NPSR1 Q6W5P4 2/20 0.41
MAPK1 P28482 1/20 0.41
BLM P54132 1/20 0.41
HTT P42858 3/20 0.41
KDM4E B2RXH2 3/20 0.41
HDAC1 Q13547 3/20 0.41
HPGD P15428 3/20 0.40
TSHR P16473 2/20 0.40
CASP1 P29466 1/20 0.40
MAPK10 P53779 1/20 0.40
CASP7 P55210 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6756368 0.82 HDAC1 (0.42) LMNAKDM4EHDAC1TSHRSMN1; SMN2
SCHEMBL6759304 0.74 HRH4 (0.52) LMNAALDH1A1KDM4EHPGDTSHR
SCHEMBL6760767 0.74 HDAC1 (0.48) CLK1POLBADORA2ALMNAALDH1A1
SCHEMBL6758074 0.74 ALDH1A1 (0.44) LMNAALDH1A1MAPK1HTTKDM4E
SCHEMBL6602659 0.73 HDAC1 (0.52) CLK1POLBLMNAALDH1A1NPSR1
SCHEMBL6602111 0.70 POLB (0.59) POLBLMNAALDH1A1HTTKDM4E
SCHEMBL6755064 0.68 FNTA (0.46) LMNAALDH1A1NPSR1MAPK1BLM
SCHEMBL6759320 0.66 HDAC1 (0.52) CLK1ADORA3ADORA2AADORA2BLMNA
SCHEMBL6759297 0.66 HRH4 (0.47) LMNAKDM4ETSHRNPC1RAB9A
SCHEMBL13494013 0.66 SENP1 (0.58) CLK1LMNAALDH1A1NPSR1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040204417-A1 Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins PIERRE FABRE MEDICAMENT (FR) 2004-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040204417-A1 Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins CBR1, CBR3, HCCS SLC40A1 3980/4885CLK1 3241/4885POLB 4034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.